A two-year evaluation of the minutes of Investigational New Drug committee meetings

INTRODUCTION: The Investigational New Drug (IND) committee advises the Drug Controller General of India on matters pertaining to clinical trials (CTs) of IND for clinical development. An audit of the minutes of this committee's meetings would shed light on the drug discovery in India. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Raj, Jeffrey Pradeep, Gogtay, Nithya J., Thatte, Urmila M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525788/
https://www.ncbi.nlm.nih.gov/pubmed/34760647
http://dx.doi.org/10.4103/picr.PICR_83_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525788/
https://www.ncbi.nlm.nih.gov/pubmed/34760647
http://dx.doi.org/10.4103/picr.PICR_83_19

Ejemplares similares